The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin–induced intestinal fluid secretion
Abstract
Secretory diarrhea is the leading cause of infant death in developing countries and a major cause of morbidity in adults. The cystic fibrosis transmembrane conductance regulator (CFTR) protein is required for fluid secretion in the intestine and airways and, when defective, causes the lethal genetic disease cystic fibrosis. We screened 50,000 chemically diverse compounds for inhibition of cAMP/flavone–stimulated Cl– transport in epithelial cells expressing CFTR. Six CFTR inhibitors of the 2-thioxo-4-thiazolidinone chemical class were identified. The most potent compound discovered by screening of structural analogs, CFTRinh-172, reversibly inhibited CFTR short-circuit current in less than 2 minutes in a voltage-independent manner with KI approximately 300 nM. CFTRinh-172 was nontoxic at high concentrations in cell culture and mouse models. At concentrations fully inhibiting CFTR, CFTRinh-172 did not prevent elevation of cellular cAMP or inhibit non-CFTR Cl– channels, multidrug resistance protein-1 (MDR-1), ATP-sensitive K+ channels, or a series of other transporters. A single intraperitoneal injection of CFTRinh-172 (250 μg/kg) in mice reduced by more than 90% cholera toxin–induced fluid secretion in the small intestine over 6 hours. Thiazolidinone CFTR inhibitors may be useful in developing large-animal models of cystic fibrosis and in reducing intestinal fluid loss in cholera and other secretory diarrheas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Snyder, J. D., & MERSON, M. H. (1982) · Europe PMC (PubMed Central) · Cited by 1,003
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels*
Aguilar-Bryan, L., & Bryan, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.2.0361 · Cited by 698
Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins
Kimberg, D. V., Field, M., Johnson, J., Henderson, A., & Gershon, E. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106599 · Cited by 600
Genetic Analysis of Italian Patients with Congenital Hyperinsulinism of Infancy
Sogno Valin, P., Proverbio, M. C., Diceglie, C., Gessi, A., di Candia, S., Mariani, B., Zamproni, I., Mangano, E., Asselta, R., Battaglia, C., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000350827 · Cited by 552
Cystic Fibrosis Heterozygote Resistance to Cholera Toxin in the Cystic Fibrosis Mouse Model
Gabriel, S. E., Brigman, K. N., Koller, B. H., Boucher, R. C., & Stutts, M. J. (1994) · Science · doi:10.1126/science.7524148 · Cited by 482
Role of CFTR in Airway Disease
PILEWSKI, J. M., & FRIZZELL, R. A. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s215 · Cited by 447
Pathophysiology of Gene-Targeted Mouse Models for Cystic Fibrosis
GRUBB, B. R., & BOUCHER, R. C. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s193 · Cited by 410
Chemical probes for anion transporters of mammalian cell membranes
Cabantchik, Z. I., & Greger, R. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.4.c803 · Cited by 380
Sheppard, D. N., & Welsh, M. J. (1992) · The Journal of general physiology · doi:10.1085/jgp.100.4.573 · Cited by 322
Pharmacology of CFTR Chloride Channel Activity
SCHULTZ, B. D., SINGH, A. K., DEVOR, D. C., & BRIDGES, R. J. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s109 · Cited by 282
Cited by
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
Targeting virulence: a new paradigm for antimicrobial therapy
Clatworthy, A. E., Pierson, E., & Hung, D. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.24 · Cited by 1,406
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Cao, D., Neuberger, T., Turnbull, A., Singh, A., Joubran, J., Hazlewood, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904709106 · Cited by 1,228
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
Jiang, H., He, H., Chen, Y., Huang, W., Cheng, J., Ye, J., Wang, A., Tao, J., Wang, C., Liu, Q., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171419 · Cited by 748
Mucus Clearance and Lung Function in Cystic Fibrosis with Hypertonic Saline
Donaldson, S. H., Bennett, W. D., Zeman, K. L., Knowles, M. R., Tarran, R., & Boucher, R. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043891 · Cited by 694
Pharmacological Inhibitors of the NLRP3 Inflammasome
Zahid, A., Li, B., Kombe, A. J. K., Jin, T., & Tao, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02538 · Cited by 671
CFTR Function and Prospects for Therapy
Riordan, J. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142532 · Cited by 610
Intestinal ion transport and the pathophysiology of diarrhea
Field, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18326 · Cited by 572
Pedemonte, N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24898 · Cited by 538
Structure and Function of TMEM16 Proteins (Anoctamins)
Pedemonte, N., & Galietta, L. J. V. (2014) · Physiological Reviews · doi:10.1152/physrev.00039.2011 · Cited by 520
Self-citationVan Goor, F., Straley, K. S., Cao, D., González, J., Hadida, S., Hazlewood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00169.2005 · Cited by 512
CFTR regulates phagosome acidification in macrophages and alters bactericidal activity
Di, A., Brown, M. E., Deriy, L. V., Li, C., Szeto, F. L., Chen, Y., Huang, P., Tong, J., Naren, A. P., Bindokas, V., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1456 · Cited by 492
Chloride channels as drug targets
Verkman, A. S., & Galietta, L. J. V. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2780 · Cited by 469
Self-citationStevioside and related compounds: Therapeutic benefits beyond sweetness
Chatsudthipong, V., & Muanprasat, C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.007 · Cited by 467
Clayburgh, D. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24970 · Cited by 426
Namkung, W., Phuan, P.-W., & Verkman, A. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.175109 · Cited by 353
Self-citationActivating AMP-activated protein kinase (AMPK) slows renal cystogenesis
Takiar, V., Nishio, S., Seo-Mayer, P., King, J. D., Li, H., Zhang, L., Karihaloo, A., Hallows, K. R., Somlo, S., & Caplan, M. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011498108 · Cited by 345
Gustafsson, J. K., Ermund, A., Ambort, D., Johansson, M. E. V., Nilsson, H. E., Thorell, K., Hebert, H., Sjövall, H., & Hansson, G. C. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120562 · Cited by 345
4-Thiazolidinones: The advances continue…
Tripathi, A. C., Gupta, S. J., Fatima, G. N., Sonar, P. K., Verma, A., & Saraf, S. K. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.017 · Cited by 319
Zachos, N. C., Kovbasnjuk, O., Foulke-Abel, J., In, J., Blutt, S. E., de Jonge, H. R., Estes, M. K., & Donowitz, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.635995 · Cited by 297
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Xu, W., Huang, Y., & Zhou, R. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01275-w · Cited by 295
A cation counterflux supports lysosomal acidification
Steinberg, B. E., Huynh, K. K., Brodovitch, A., Jabs, S., Stauber, T., Jentsch, T. J., & Grinstein, S. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911083 · Cited by 277
Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors
Muanprasat, C., Sonawane, N. D., Salinas, D., Taddei, A., Galietta, L. J. V., & Verkman, A. S. (2004) · The Journal of General Physiology · doi:10.1085/jgp.200409059 · Cited by 264
Self-citationStructure, Gating, and Regulation of the CFTR Anion Channel
Csanády, L., Vergani, P., & Gadsby, D. C. (2019) · Physiological Reviews · doi:10.1152/physrev.00007.2018 · Cited by 262
WIMMERS, S., KARL, M., & STRAUSS, O. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.12.002 · Cited by 207
Haggie, P. M., Cil, O., Lee, S., Tan, J.-A., Rivera, A. A., Phuan, P.-W., & Verkman, A. S. (2018) · JCI Insight · doi:10.1172/jci.insight.121370 · Cited by 56
“YFP-based assays of CFTR, pendrin, and TMEM16A were as described (19, 26, 47, 48).”
MethodSelf-citationCFTR in cystic fibrosis and cholera: from membrane transport to clinical practice
Goodman, B. E., & Percy, W. H. (2005) · Advances in Physiology Education · doi:10.1152/advan.00035.2004 · Cited by 41
Thomas, A., Ramananda, Y., Mun, K., Naren, A. P., & Arora, K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003378 · Cited by 22
“We used the closed ileal loop model in mice to test CTX-induced fluid secretion (3, 6, 16, 17).”
BackgroundMethod
Metadata
- Authors
- Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J. V., & Verkman, A. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-12-01
- Volume
- 110
- Issue
- 11
- Pages
- 1651-1658
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4233502188
- Cited by
- 536
- References
- 22
- FWCI
- 14.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.